On November 19, CHERVON fell 4.19% in Regular Trading, trading at HK$30.58, with turnover of HK$6.46 million.
The move coincided with continued market digestion of the US litigation involving CHERVON, its North America unit, and newly appointed CEO Joseph Galli, which has remained a key sentiment overhang on the stock.
Publicly disclosed details show the lawsuit was filed by North American units of a competitor in federal court in Illinois, alleging eight causes of action including trade secret misappropriation, tortious interference, and unfair competition. The complaint alleges that within 54 days of Galli's September 10 appointment, at least 18 executives and key staff were recruited and confidential Milwaukee-related materials were obtained. While some brokers had previously raised target prices and maintained constructive ratings after stronger interim results and management changes, short-term trading has remained focused on litigation uncertainty.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments